Financials
Financial year 2025
Worth noting
- More debts than assets in the latest financial year.
- A loss two years in a row.
Gross margin
€ 3.1 million
▲ 163% vs 2024
Profit
Caution€ -3.3 million
▼ 2% vs 2024
Debts
High€ 4 million
▼ 26% vs 2024
REJUVENATE BIOMED from Diepenbeek, company number BE0681964735, closed financial year 2025 with a result of € -3.3 million after tax. For that financial year REJUVENATE BIOMED recorded a gross margin of € 3.1 million and equity of € -543,937. Compared with financial year 2024, the result moved from € -3.2 million to € -3.3 million. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 30, 2026.
What happened at REJUVENATE BIOMED?
What happened at REJUVENATE BIOMED in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Ann Beliën stepped down as director. NBB
- Stéphane Verdood stepped down as director. NBB
- Glenn Van Dael stepped down as director. NBB
- Sunathim BV stepped down as director. NBB
- New annual accounts for financial year 2025: loss of € 3.3 million. Source: NBB ↗
- New establishment in Diepenbeek. KBO
- Sunathim BV became a director. NBB
- Stéphane Verdood became a director. NBB
In short
From € 1.8 million loss in 2021 to € 3.3 million loss in 2025.
On average € 281,100 of value added per employee in 2025.
A new publication or filing at REJUVENATE BIOMED? We notify you, reason included.
Follow REJUVENATE BIOMEDNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Directors
According to the 2025 annual accounts
Director · represented by Shetty Sunangal Ajit
Also active at: SOUDAL HOLDING, reMYND, Newton Biocapital I, pricaf privée de droit belge +1 more
since 2022 · until 2028
Ann Beliën
Managing director
since 2017 · until 2029
Stéphane Verdood
Director
since 2021 · until 2029
Glenn Van Dael
Director
since 2017 · until 2029
Establishments
Establishment units
Physical locations of this company
Agoralaan A-bis
3590 Diepenbeek
Agoralaan 1 box A
3590 Diepenbeek
Active since 1 July 2022
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 3 companies are registered at this address.
Details
- Company number
- 0681.964.735
- VAT number
- BE 0681.964.735
- Registered office
- Agoralaan A-bis, 3590 Diepenbeek
- Names & denominations
- REJUVENATE BIOMED
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 2 October 2017
- Peppol
- Active · Active since 30 Oct 2025
- Activities · NACE
Speur- en ontwikkelingswerk op biotechnologisch gebied
Vervaardiging van farmaceutische grondstoffen